SCHEMBL8980424

SCHEMBL8980424

Cc1c(C)c2c(c(C)c1O)C(=O)CC(C)(COc1ccc([N+](=O)[O-])cc1)O2

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.44
MEN1 O00255 2/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
MAPT P10636 4/20 0.42
TDP1 Q9NUW8 1/20 0.42
ALDH1A1 P00352 1/20 0.39
PKM P14618 2/20 0.36
KDM4E B2RXH2 1/20 0.36
PPARG P37231 1/20 0.35
PTGS2 P35354 1/20 0.34
MAOB P27338 2/20 0.34
AOC3 Q16853 1/20 0.34
CRHBP P24387 1/20 0.34
CRHR2 Q13324 1/20 0.34
CTDSP1 Q9GZU7 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9531639 0.91 KMT2A (0.42) KMT2AMEN1NPC1RAB9AMAPT
SCHEMBL8980246 0.86 MEN1 (0.44) KMT2AMEN1NPC1RAB9AMAPT
SCHEMBL8177483 0.85 KMT2A (0.39) KMT2AMEN1NPC1RAB9AMAPT
SCHEMBL9632315 0.84 KMT2A (0.42) KMT2AMEN1NPC1RAB9AMAPT
SCHEMBL7127125 0.83 KMT2A (0.44) KMT2AMEN1NPC1MAPTALDH1A1
SCHEMBL9534457 0.81 MAPT (0.45) KMT2AMEN1NPC1RAB9AMAPT
SCHEMBL9630982 0.81 KMT2A (0.36) KMT2AMEN1NPC1RAB9AMAPT
SCHEMBL9632107 0.80 MAPT (0.60) KMT2AMEN1MAPTTDP1PPARG
SCHEMBL9630952 0.79 TTPA (0.41) KMT2AMEN1NPC1RAB9AMAPT
SCHEMBL10640704 0.79 PPARG (0.46) KMT2AMEN1NPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0556830-B1 Method for the preparation of 6-hydroxy-2,5,7,8-tetraalkyl-2-(4-aminophenoxymethyl)chromans LONZA AG (CH) 1996-04-24 EP disclosed
EP-0556831-B1 Method for the preparation of 6-hydroxy-2,5,7,8-tetraalkyl-2-(4-aminophenoxymethyl)chromans LONZA AG (CH) 1995-11-02 EP disclosed
US-5310952-A Method for the preparation of 6-hydroxy-2,5,7,8-tetraalkyl-2-(4-aminophenoxymethyl) chromans LONZA LTD. (CH) 1994-05-10 US disclosed
US-5284961-A Process for the preparation of 6-hydroxy-2,5,7,8-tetraalkyl-2-(4-aminophenoxymethyl) chromans LONZA LTD. (CH) 1994-02-08 US disclosed
EP-0556830-A1 Method for the preparation of 6-hydroxy-2,5,7,8-tetraalkyl-2-(4-aminophenoxymethyl)chromans LONZA AG (CH) 1993-08-25 EP disclosed
EP-0556831-A1 Method for the preparation of 6-hydroxy-2,5,7,8-tetraalkyl-2-(4-aminophenoxymethyl)chromans LONZA AG (CH) 1993-08-25 EP disclosed
US-5104888-A Anticholesterol or antidiabetic agents SANKYO COMPANY, LIMITED (JP) 1992-04-14 US disclosed
EP-0207581-B1 THIAZOLIDINE DERIVATIVES, THEIR PREPARATION AND USE SANKYO COMPANY LIMITED (JP) 1990-09-12 EP disclosed
EP-0139421-B1 THIAZOLIDINE DERIVATIVES, THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM SANKYO COMPANY LIMITED (JP) 1988-04-27 EP disclosed
EP-0207581-A2 Thiazolidine derivatives, their preparation and use SANKYO COMPANY LIMITED (JP) 1987-01-07 EP disclosed
US-4572912-A Thiazolidine derivatives, their preparation and compositions containing them SANKYO COMPANY LIMITED (JP) 1986-02-25 US disclosed
EP-0139421-A1 Thiazolidine derivatives, their preparation and compositions containing them SANKYO COMPANY LIMITED (JP) 1985-05-02 EP disclosed